// App-Quantinova.ai

THU0309 : LOW-DOSE ASPIRIN AS PRIMARY PROPHYLAXIS FOR CARDIOVASCULAR EVENTS IN SYSTEMIC LUPUS ERYTHEMATOSUS: A LONG-TERM FOLLOW UP

Researchers

Presenter

  • S. Fasano

Principal Investigators

  • M. Iudici

  • I. Pantano

  • L. Pierro

  • G. Valentini

Medical Centers

  • Urology Unit, SecondUniversity of Naples, Napoli, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Lupus

  • Venous thrombosis

Biomarkers

  • Albumin/creatinine

Drug/Treatment

  • Albyl-E

  • Aspirin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved